eNOS Deficient Mice Develop Progressive Cardiac Hypertrophy with Altered Cytokine and Calcium Handling Protein Expression
Authors:
- 3 August 2007
- journal article
- Published by Springer Nature in Cardiovascular Toxicology
- Vol. 7 (3) , 165-177
Abstract
Although studies have shown that endothelial nitric oxide synthase (eNOS) homozygous knockout mice (eNOS−/−) develop left ventricular (LV) hypertrophy, well compensated at least to 24 wks, uncertainty still exists as to the cardiac functional and molecular mechanistic consequences of eNOS deficiency at later time-points. To bridge the gap in existent data, we examined whole hearts from eNOS−/− and age-matched wild-type (WT) control mice ranging in age from 18 to 52 wks for macroscopic and microscopic histopathology, LV mRNA and protein expression using RNA Dot blots and Western blots, respectively, and LV function using isolated perfused work-performing heart preparations. Heart weight to body weight (HW/BW in mg/g) ratio increased significantly as eNOS−/− mice aged (82.2%, P < 0.001). Multi-focal replacement fibrosis and myocyte degeneration/death were first apparent in eNOS−/− mouse hearts at 40 wks. Progressive increases in LV atrial natriuretic factor (ANF) and α-skeletal actin mRNA levels both correlated significantly with increasing HW/BW ratio in aged eNOS−/− mice (r = 0.722 and r = 0.648, respectively; P < 0.001). At 52 wks eNOS−/− mouse hearts exhibited basal LV hypercontractility yet blunted beta adrenergic receptor (βAR) responsiveness that coincided with a significant reduction in the LV ratio of phospholamban to sarcoplasmic reticulum Ca2+-ATPase-2a protein levels and was preceded by a significant upregulation in LV steady-state mRNA and protein levels of the 28 kDa membrane-bound form of tumor necrosis factor-alpha. We conclude that absence of eNOS in eNOS−/− mice results in a progressive concentric hypertrophic cardiac phenotype that is functionally compensated with decreased βAR responsiveness, and is associated with a potential cytokine-mediated alteration of calcium handling protein expression.Keywords
This publication has 41 references indexed in Scilit:
- Cardioprotection afforded by NF-κB ablation is associated with activation of Akt in mice overexpressing TNF-αAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overloadCardiovascular Research, 2005
- Tumour necrosis factor-alpha in diastolic dysfunctionActa Cardiologica, 2004
- Inotropic response to β‐adrenergic receptor stimulation and anti‐adrenergic effect of ACh in endothelial NO synthase‐deficient mouse heartsThe Journal of Physiology, 2001
- Endothelial Nitric Oxide Gene Knockout MiceHypertension, 1999
- Pentameric Assembly of Phospholamban Facilitates Inhibition of Cardiac Function in VivoJournal of Biological Chemistry, 1998
- The relative phospholamban and SERCA2 ratio: a critical determinant of myocardial contractilityBasic Research in Cardiology, 1997
- Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart.Journal of Clinical Investigation, 1996
- A Noninvasive Computerized Tail-Cuff System for Measuring Blood Pressure in MiceHypertension, 1995
- Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric OxideScience, 1992